| In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 |
| | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K |
| Revenues [+] | 4.3 | 1.0 | 0.0 | 0.0 | 7.0 | 1.5 | 2.2 | 2.5 |
| Healthcare | | | | | | 1.9 | 2.4 | 1.1 |
| Net interest income | | | | | | -0.5 | -0.2 | -0.2 |
| Revenue growth | 321.0% | | -100.0% | -100.0% | 374.9% | -32.9% | -12.6% | 6.1% |
| Cost of goods sold [+] | 3.7 | 0.8 | 0.0 | 0.0 | 0.0 | 1.6 | 1.9 | 1.1 |
| Labor costs | | | | | | 0.7 | 0.8 | |
| Supplies costs | | | | | | 0.9 | 1.1 | |
| Direct taxes | 0.2 | 0.2 | | | | | | |
| Gross profit | 0.6 | 0.2 | 0.0 | 0.0 | 7.0 | -0.1 | 0.3 | 1.4 |
| Gross margin | 13.1% | 18.6% | | 0.0% | 100.0% | -7.9% | 15.0% | 56.1% |
| Selling, general and administrative [+] | 11.3 | 1.3 | 0.1 | 0.0 | 0.0 | 0.2 | 0.3 | 0.6 |
| Sales and marketing | 0.1 | 0.0 | | | | | | |
| General and administrative [+] | 8.6 | 0.8 | | 0.0 | 0.0 | 0.2 | 0.3 | 0.6 |
| General and administrative expenses | 11.1 | 1.2 | | 0.0 | 0.0 | 0.2 | 0.3 | 0.6 |
| Professional fees | 8.6 | 0.8 | | | | | | |
| Other selling, general and administrative | 2.6 | 0.4 | | | | | | |
| Other operating expenses | 4.0 | 1.0 | | | 0.0 | 2.5 | 0.1 | 0.7 |
| EBITDA [+] | -14.7 | -2.0 | | | | -2.9 | 0.0 | 0.1 |
| EBITDA growth | 620.2% | 2628.1% | 7490.3% | -100.0% | -345.3% | 5949.2% | -153.7% | -245.5% |
| EBITDA margin | -345.3% | -201.9% | | -100.0% | 100.0% | -193.6% | -2.1% | 3.5% |
| Depreciation | 0.0 | 0.0 | | | | 0.4 | 0.3 | 0.1 |
| EBITA | -14.7 | -2.1 | -0.1 | 0.0 | 7.0 | -3.2 | -0.3 | 0.0 |
| EBITA margin | -346.1% | -203.3% | | -100.0% | 100.0% | -217.6% | -13.8% | -0.5% |
| Amortization of intangibles | 0.0 | | | | | | | |
| EBIT [+] | -14.7 | -2.1 | -0.1 | 0.0 | 7.0 | -3.2 | -0.3 | 0.0 |
| EBIT growth | 617.0% | 2648.1% | 7490.3% | -100.0% | -318.1% | 957.3% | 2375.3% | -94.7% |
| EBIT margin | -346.3% | -203.3% | | -100.0% | 100.0% | -217.6% | -13.8% | -0.5% |
| Non-recurring items [+] | | 0.2 | | | 7.0 | -2.7 | 0.2 | 0.3 |
| Asset impairment | | 0.2 | | | | | 0.2 | 0.3 |
| Loss (gain) on sale of assets | | | | | 7.0 | -2.7 | | |
| Interest expense, net [+] | 2.2 | 0.2 | | | | | | 0.0 |
| Interest expense | 2.2 | 0.2 | | | | | | |
| Interest income | | | | | | | | 0.0 |
| Other income (expense), net [+] | -5.4 | -0.1 | | | 6.2 | -0.4 | -0.1 | -0.2 |
| Gain (loss) on derivative instruments | -1.0 | 0.1 | | | | | | |
| Gain (loss) on foreign currency transactions | | | | | | | | -51.2 |
| Other non-operating income | | | | | | 0.0 | 0.0 | |
| Other | -0.2 | 0.0 | | | | 0.0 | 0.0 | 0.0 |
| Pre-tax income | -22.2 | -2.6 | -0.1 | 0.0 | 6.2 | -1.0 | -0.6 | -0.5 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Earnings from continuing ops | -22.2 | -2.6 | -0.1 | 0.0 | 6.2 | -3.6 | -0.6 | -0.5 |
| Earnings from discontinued ops | | | | | 6.2 | | | |
| Net income | -22.2 | -2.6 | -0.1 | 0.0 | 6.2 | -3.6 | -0.6 | -0.5 |
| Net margin | -523.0% | -255.1% | | -100.0% | 87.7% | -246.1% | -26.7% | -18.3% |
| |
| Basic EPS [+] | ($0.23) | ($0.05) | $0.00 | $0.00 | $0.39 | ($0.23) | ($0.04) | ($0.03) |
| Growth | 372.5% | 1582.8% | 4619.8% | -100.0% | -269.3% | 518.6% | 27.4% | -36.7% |
| Diluted EPS [+] | ($0.23) | ($0.05) | $0.00 | $0.00 | $0.39 | ($0.23) | ($0.04) | ($0.03) |
| Growth | 372.5% | 1582.8% | 4619.8% | -100.0% | -269.3% | 518.6% | 27.4% | -36.7% |
| |
| Shares outstanding (basic) [+] | 95.2 | 52.1 | 25.4 | 15.8 | 15.8 | 15.8 | 15.8 | 15.8 |
| Growth | 82.6% | 104.9% | 60.8% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Shares outstanding (diluted) [+] | 95.2 | 52.1 | 25.4 | 15.8 | 15.8 | 15.8 | 15.8 | 15.8 |
| Growth | 82.6% | 104.9% | 60.8% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |